The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Egecioglu, Emil ^a   Engel, Jörgen A ^a   Jerlhag, Elisabet ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; CENTRAL STIMULANT AGENT; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; LIRAGLUTIDE; PEPTIDE; VENOM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG MECHANISM; IN VIVO STUDY; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; MOUSE; NONHUMAN; PLACE PREFERENCE; REWARD; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; GLUCAGON-LIKE PEPTIDE 1; MALE; MICE; MOTOR ACTIVITY; PEPTIDES; RECEPTORS, GLUCAGON; VENOMS;

EID: 84880459479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069010     Document Type: Article

References (54)

1. Brubaker PL, Anini Y, (2003) Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81: 1005-1012. doi:10.1139/y03-107. PubMed: 14719035.
2. Novak U, Wilks A, Buell G, McEwen S, (1987) Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem 164: 553-558. doi:10.1111/j.1432-1033.1987.tb11162.x. PubMed: 3569278.
3. Alvarez E, Roncero I, Chowen JA, Thorens B, Blázquez E, (1996) Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem 66: 920-927. PubMed: 8769850.
4. Merchenthaler I, Lane M, Shughrue P, (1999) Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403: 261-280. doi:10.1002/(SICI)1096-9861(19990111)403:2. PubMed: 9886047.
5. Holst JJ, (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439. doi:10.1152/physrev.00034.2006. PubMed: 17928588.
6. Baggio LL, Drucker DJ, (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157. doi:10.1053/j.gastro.2007.03.054. PubMed: 17498508.
7. McMahon LR, Wellman PJ, (1998) PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol 274: R23-R29. PubMed: 9458894.
8. Kreymann B, Williams G, Ghatei MA, Bloom SR, (1987) Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1304. PubMed: 2890903.
9. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, et al. (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72. doi:10.1038/379069a0. PubMed: 8538742.
10. Tang-Christensen M, Larsen PJ, Göke R, Fink-Jensen A, Jessop DS, et al. (1996) Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271: R848-R856. PubMed: 8897973.
11. Holst JJ, Vilsbøll T, Deacon CF, (2009) The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297: 127-136. doi:10.1016/j.mce.2008.08.012. PubMed: 18786605.
12. Matsuyama T, Komatsu R, Namba M, Watanabe N, Itoh H, et al. (1988) Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone. Diabetes Res Clin Pract 5: 281-284. doi:10.1016/S0168-8227(88)80063-9. PubMed: 3069410.
13. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S, (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326: 1316-1322. doi:10.1056/NEJM199205143262003. PubMed: 1348845.
14. Schirra J, Kuwert P, Wank U, Leicht P, Arnold R, et al. (1997) Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians 109: 84-97. PubMed: 9010920.
15. Rawson RA, Condon TP, (2007) Why do we need an Addiction supplement focused on methamphetamine? Addiction 102 (Suppl 1):: 1-4. doi:10.1111/j.1360-0443.2007.01951.x. PubMed: 17493048.
16. Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P, (2001) Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev: 003022. PubMed: 11687171.
17. Koob GF, Le Moal M, (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129. doi:10.1016/S0893-133X(00)00195-0. PubMed: 11120394.
18. Larsson A, Engel JA, (2004) Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev 27: 713-720. doi:10.1016/j.neubiorev.2003.11.010. PubMed: 15019421.
19. Volkow ND, Li TK, (2004) Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 5: 963-970. doi:10.1038/nrn1539. PubMed: 15550951.
20. Tupala E, Tiihonen J, (2004) Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 28: 1221-1247. doi:10.1016/j.pnpbp.2004.06.022. PubMed: 15588749.
21. Jerlhag E, Egecioglu E, Landgren S, Salomé N, Heilig M, et al. (2009) Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A 106: 11318-11323. doi:10.1073/pnas.0812809106. PubMed: 19564604.
22. Wise RA, Bozarth MA, (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492. doi:10.1037/0033-295X.94.4.469. PubMed: 3317472.
23. Thorens B, Porret A, Bühler L, Deng SP, Morel P, et al. (1993) Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42: 1678-1682. doi:10.2337/diabetes.42.11.1678. PubMed: 8405712.
24. Göke R, Larsen PJ, Mikkelsen JD, Sheikh SP, (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7: 2294-2300. doi:10.1111/j.1460-9568.1995.tb00650.x. PubMed: 8563978.
25. Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel JA, et al. (2013) The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology, 38: 1259-70. PubMed: 23219472.
26. Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, et al. (2006) Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11: 45-54. doi:10.1111/j.1369-1600.2006.00002.x. PubMed: 16759336.
27. Franklin KBJ, Paxinos G, (1996) The Mouse Brain in Stereotaxic Coordinates. New York: Academic Press.
28. Jerlhag E, Engel JA, (2011) Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend 117: 126-131. doi:10.1016/j.drugalcdep.2011.01.010. PubMed: 21310553.
29. Kastin AJ, Akerstrom V, (2003) Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 27: 313-318. doi:10.1038/sj.ijo.0802206. PubMed: 12629557.
30. Rinaman L, (2010) Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 1350: 18-34. doi:10.1016/j.brainres.2010.03.059. PubMed: 20353764.
31. Alhadeff AL, Rupprecht LE, Hayes MR, (2012) GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153: 647-658. doi:10.1210/en.2011-1443. PubMed: 22128031.
32. Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, et al. (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32: 4812-4820. doi:10.1523/JNEUROSCI.6326-11.2012. PubMed: 22492036.
33. Dossat AM, Lilly N, Kay K, Williams DL, (2011) Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 31: 14453-14457. doi:10.1523/JNEUROSCI.3262-11.2011. PubMed: 21994361.
34. Heusner CL, Hnasko TS, Szczypka MS, Liu Y, During MJ, et al. (2003) Viral restoration of dopamine to the nucleus accumbens is sufficient to induce a locomotor response to amphetamine. Brain Res 980: 266-274. doi:10.1016/S0006-8993(03)02986-X. PubMed: 12867267.
35. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238. doi:10.1038/npp.2009.110. PubMed: 19710631.
36. Owens WA, Sevak RJ, Galici R, Chang X, Javors MA, et al. (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem 94: 1402-1410. doi:10.1111/j.1471-4159.2005.03289.x. PubMed: 15992364.
37. Thompson D, Martini L, Whistler JL,. (2010) Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine. PLOS ONE 5: e11038. doi:10.1371/journal.pone.0011038. PubMed: 20543951.
38. Hayes MR, Bradley L, Grill HJ, (2009) Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 150: 2654-2659. doi:10.1210/en.2008-1479. PubMed: 19264875.
39. Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ, (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57: 2046-2054. doi:10.2337/db07-1824. PubMed: 18487451.
40. Rüttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W, (2009) Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150: 1174-1181. PubMed: 18948395.
41. Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR, (2012) The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 62: 1916-1927. doi:10.1016/j.neuropharm.2011.12.022. PubMed: 22227019.
42. Cagniard B, Murphy NP, (2013) Affective taste responses in the presence of reward- and aversion-conditioned stimuli and their relationship to psychomotor sensitization and place conditioning. Behav Brain Res 236: 289-294. PubMed: 22940019.
43. Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, et al. (2012) Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav 106: 574-578. doi:10.1016/j.physbeh.2012.03.014. PubMed: 22465309.
44. Everitt BJ, Wolf ME, (2002) Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22: 3312-3320. PubMed: 11978805.
45. Wise RA, (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5: 483-494. doi:10.1038/nrg1390. PubMed: 15152198.
46. Wise RA, Rompre PP, (1989) Brain dopamine and reward. Annu Rev Psychol 40: 191-225. doi:10.1146/annurev.ps.40.020189.001203. PubMed: 2648975.
47. Graham DL, Erreger K, Galli A, Stanwood GD, (2012) GLP-1 analog attenuates cocaine reward. Mol Psychiatry: ([MedlinePgn:]) doi:10.1038/mp.2012.141. PubMed: 23089631. PubMed: 23089631.
48. Morganstern I, Barson JR, Leibowitz SF, (2011) Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drug Abuse Rev 4: 163-173. doi:10.2174/1874473711104030163. PubMed: 21999690.
49. Wellman PJ, Davis KW, Nation JR, (2005) Augmentation of cocaine hyperactivity in rats by systemic ghrelin. Regul Pept 125: 151-154. doi:10.1016/j.regpep.2004.08.013. PubMed: 15582726.
50. Wellman PJ, Nation JR, Davis KW, (2007) Impairment of acquisition of cocaine self-administration in rats maintained on a high-fat diet. Pharmacol Biochem Behav 88: 89-93. doi:10.1016/j.pbb.2007.07.008. PubMed: 17764729.
51. Clifford PS, Rodriguez J, Schul D, Hughes S, Kniffin T, et al. (2012) Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors. Addict Biol. doi:10.1111/j. 1369-1600.2011.00339.x.
52. Jerlhag E, Egecioglu E, Dickson SL, Engel JA, (2010) Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl) 211: 415-422. doi:10.1007/s00213-010-1907-7. PubMed: 20559820.
53. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A, (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589-601. doi:10.1016/j.neuron.2006.01.016. PubMed: 16476667.
54. Opland DM, Leinninger GM, Myers MG Jr., (2010) Modulation of the mesolimbic dopamine system by leptin. Brain Res 1350: 65-70. doi:10.1016/j.brainres.2010.04.028. PubMed: 20417193.